Immunohistochemical Tumor Expression Predicts Response to CD3xCD20 Bispecific Antibodies in Patients with Relapsed/Refractory B Cell Lymphoma

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalBlood
Volume142
Issue numberSupplement 1
Pages (from-to)6113-6113
ISSN0006-4971
DOIs
Publication statusPublished - 28 Nov 2023

ID: 386604816